000 01754 a2200529 4500
005 20250513224045.0
264 0 _c20001214
008 200012s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.118.5.1278
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHilleman, D E
245 0 0 _aPharmacoeconomic evaluation of COPD.
_h[electronic resource]
260 _bChest
_cNov 2000
300 _a1278-85 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aClinical Laboratory Techniques
_xeconomics
650 0 4 _aCohort Studies
650 0 4 _aCost of Illness
650 0 4 _aEconomics, Pharmaceutical
650 0 4 _aEmergency Service, Hospital
_xeconomics
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aForced Expiratory Volume
_xphysiology
650 0 4 _aHealth Care Costs
650 0 4 _aHealth Facilities
_xeconomics
650 0 4 _aHealth Resources
_xstatistics & numerical data
650 0 4 _aHospitalization
_xeconomics
650 0 4 _aHumans
650 0 4 _aLung Diseases, Obstructive
_xclassification
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxygen Inhalation Therapy
_xeconomics
650 0 4 _aRespiratory System Agents
_xeconomics
650 0 4 _aRetrospective Studies
650 0 4 _aStatistics, Nonparametric
650 0 4 _aTreatment Outcome
650 0 4 _aVital Capacity
_xphysiology
700 1 _aDewan, N
700 1 _aMalesker, M
700 1 _aFriedman, M
773 0 _tChest
_gvol. 118
_gno. 5
_gp. 1278-85
856 4 0 _uhttps://doi.org/10.1378/chest.118.5.1278
_zAvailable from publisher's website
999 _c11025331
_d11025331